These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1029920)

  • 1. [Electrocardiographic changes in hereditary cardiomyopathy of the Syrian hamster].
    Lossnitzer K; Grewe N; Konrad A; Stauch M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1057-60. PubMed ID: 1029920
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polymyopathy and hereditary cardiomyopathy in the Syrian hamster. Selective inhibition of myocardial lesions].
    Jasmin G; Bajusz E
    Ann Anat Pathol (Paris); 1973; 18(1):49-65. PubMed ID: 4146098
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of myocardial necroses in hereditary cardiopathy of the Syrian golden hamster].
    Lossnitzer K; Mohr W; Stauch M
    Verh Dtsch Ges Inn Med; 1975; 81():335-8. PubMed ID: 1229533
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial hemodynamic observations in hereditary cardiomyopathy of the Syrian hamster.
    Abelmann WH; Wagner RL; Bajusz E
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():509-18. PubMed ID: 4806983
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of Bowditch phenomenon in the ventricular muscle of hamsters with hereditary cardiomyopathy.
    Hajdu S; Posner CJ
    Am Heart J; 1971 Jun; 81(6):781-9. PubMed ID: 5088354
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary cardiomyopathy: a new disease model.
    Bajusz E
    Am Heart J; 1969 May; 77(5):686-96. PubMed ID: 4888117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Amino acid patterns in hereditary cardiomyopathy of Syrian golden hamsters (type BIO 8262)].
    Kaemmerer H; Fink-Gremmels J; Lossnitzer K; Rapp K
    Berl Munch Tierarztl Wochenschr; 1987 Oct; 100(10):340-6. PubMed ID: 3426533
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypertrophy of the heart muscle in hereditary myopathy. Studies on the Syrian hamster in the electron microscopy picture].
    Bajusz E; Büchner F; Onishi S; Richers K
    Naturwissenschaften; 1969 Nov; 56(11):568-9. PubMed ID: 5362017
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myocardial electrolyte changes in hereditary cardiomyopathy as demonstrated on the Syrian golden hamster disease model].
    Lossnitzer K; Bajusz E
    Verh Dtsch Ges Inn Med; 1971; 77():910-4. PubMed ID: 5156085
    [No Abstract]   [Full Text] [Related]  

  • 10. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. II. Development of heart necrotic changes in relation to defective mitochondrial function.
    Proschek L; Jasmin G
    Muscle Nerve; 1982 Jan; 5(1):26-32. PubMed ID: 7057802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line.
    Jasmin G; Proschek L
    Muscle Nerve; 1982 Jan; 5(1):20-5. PubMed ID: 7057801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pressure and contractility of the left ventricle under various conditions in the Syrian golden hamster with hereditary cardiomyopathy].
    Stauch M; Lossnitzer K
    Verh Dtsch Ges Kreislaufforsch; 1972; 38():142-6. PubMed ID: 4663537
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiomyopathy in the Syrian hamster. Physiological and therapeutic aspects].
    Chemla D; Scalbert E; Desché P; Lecarpentier Y
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():85-7. PubMed ID: 1793330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyopathic Syrian hamster: a possible model of human disease.
    Gertz EW
    Prog Exp Tumor Res; 1972; 16():242-60. PubMed ID: 4261129
    [No Abstract]   [Full Text] [Related]  

  • 15. Left ventricular function in Syrian hamsters of different ages with hereditary cardiomyopathy.
    Stauch M; Lossnitzer K
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():283-90. PubMed ID: 1197887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of biochemical and structural changes in the development of the myocardiopathy of the Syrian hamster.
    Lochner A; Brink AJ; Van der Walt JJ
    J Mol Cell Cardiol; 1970 Mar; 1(1):47-64. PubMed ID: 5535337
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrolyte and water alterations during the life course of the BIO 14.6 Syrian golden hamster representing a disease model of a hereditary cardiomyopathy.
    Lossnitzer K; Bajusz E
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():503-5. PubMed ID: 4806981
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardioprotection by oxyfedrine in hereditary cardiomyopathic hamsters.
    Lossnitzer K; Konrad A; Mohr W; Jakob M; Stroman F
    Basic Res Cardiol; 1979; 74(6):675-86. PubMed ID: 548024
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulatory dynamics in heart failure of Syrian hamsters.
    Abelmann WH; Jeffrey FE; Wagner R
    Prog Exp Tumor Res; 1972; 16():261-73. PubMed ID: 4557235
    [No Abstract]   [Full Text] [Related]  

  • 20. Dystrophic cardiac calcinosis in C3H/HeN mice.
    Vargas KJ; Stephens LC; Clifford CB; Gray KN; Price RE
    Lab Anim Sci; 1996 Oct; 46(5):572-5. PubMed ID: 8905594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.